Level A Evidence
6 Treatment Options Available

Lung Transplant

Single and double lung transplantation for end-stage pulmonary disease

Lung transplantation offers hope for patients with end-stage lung disease when all other treatments have failed. Chinese lung transplant centers perform both single and bilateral (double) lung transplants, with bilateral becoming the preferred option for most conditions. Advanced techniques including ECMO bridging, ex-vivo lung perfusion (EVLP), and sophisticated immunosuppression protocols have improved outcomes significantly.

JCI Accredited
90%+ 1-Year Survival
Living & Deceased Donor

Condition Overview

Conditions We Treat

COPD/EmphysemaIdiopathic Pulmonary FibrosisCystic FibrosisPulmonary HypertensionBronchiectasisAlpha-1 Antitrypsin DeficiencyInterstitial Lung Disease

Core Technologies

Bilateral sequential technique • ECMO bridging • Ex-vivo lung perfusion (EVLP) • Clamshell incision • Video-assisted techniques • Lobar transplantation • Size reduction techniques

适宜人群

  • End-stage lung disease (FEV1 or FVC <30%)
  • High oxygen requirements or ventilator dependence
  • No other major organ failure
  • No active malignancy or infection
  • BMI 18-30, age typically <65
  • Strong social support and compliance history

Bilateral transplant preferred for septic lung diseases and pulmonary hypertension

建议在本地考虑

  • Patients requiring very complex re-transplants
  • Those on long-term ECMO with associated complications
  • Multi-organ failure requiring combined transplant
  • Patients with extensive chest wall abnormalities

Evidence: Bilateral lung transplant demonstrates 85-90% 1-year survival, 55-60% 5-year survival. Single lung transplant slightly lower survival but suitable for selected patients. Chinese centers report outcomes approaching international benchmarks.

Treatment Options

Bilateral (Double) Lung Transplant

手术
适合:Most end-stage lung diseases, especially septic lungs or pulmonary hypertension
技术:Bilateral sequential technique via clamshell incision
优势:Better long-term survival, lower infection risk
Surgery 6-10 hours, ICU 7-14 daysFrom $120,000
Preferred procedure for most indications

Single Lung Transplant

手术
适合:Selected COPD/emphysema, elderly patients
技术:Single lung replacement via thoracotomy or sternotomy
优势:Shorter procedure, may expand donor pool
Surgery 4-6 hours, ICU 5-10 daysFrom $100,000
Selected cases only

ECMO Bridge to Transplant

手术
适合:Critically ill, respiratory failure awaiting transplant
技术:Veno-venous ECMO for respiratory support
优势:Maintains candidacy for critically ill
Days to weeks of supportFrom $150,000 total
Specialized critical care

Ex-Vivo Lung Perfusion (EVLP)

手术
适合:Marginal donor lungs requiring assessment/reconditioning
技术:Lungs perfused outside body with specialized solution
优势:Expands donor pool, improves organ utilization
Added to transplant procedureFrom $30,000 additional
Limited specialized availability

Lobar Lung Transplant

手术
适合:Size-mismatched recipients (small adults or large children)
技术:Transplant of single lobe from deceased donor
优势:Makes transplant possible for size-mismatched pairs
Similar to standard transplantFrom $120,000
Specialized technique

Post-Transplant Pulmonary Care

药物
适合:All lung transplant recipients
技术:Immunosuppression, bronchoscopic surveillance, rehab
优势:Essential for graft survival
Lifelong surveillanceFrom $800/month
Comprehensive programs

费用对比

Bilateral Lung Transplant (Including 1-Year Follow-up)

US Transplant Center$1,400,000
UK NHS/Private$300,000
MediLink China$150,000

Save 89% vs US • Includes: surgery, hospital stay, ICU, ECMO if needed, immunosuppression, pulmonary rehabilitation, 1-year follow-up.

治疗流程

1
Evaluation1-2 weeks
  • Comprehensive pulmonary testing
  • High-resolution CT chest
  • Right heart catheterization
  • Six-minute walk test
  • Nutritional and psychosocial assessment
2
Transplant SurgeryWeek of surgery
  • Organ procurement coordination
  • Bilateral lung transplant (6-10 hours)
  • ICU recovery with ventilator support
  • Early bronchoscopic assessment
  • Immunosuppression and infection prophylaxis
3
RehabilitationMonths 1-6
  • Intensive pulmonary rehabilitation
  • Frequent bronchoscopies with biopsies
  • Rejection surveillance
  • Infection monitoring and prophylaxis
  • Gradual physical conditioning

Clinical Outcomes

1-Year Survival
85-90%
bilateral
5-Year Survival
55-60%
bilateral
FEV1 Improvement
60-80%
predicted
Bronchiolitis Rate
30-50%
at 5 years

常见问题

Is single or double lung transplant better?
Bilateral (double) lung transplant is preferred for most conditions due to better survival and lower infection risk. Single lung may be considered for selected COPD patients or due to donor constraints.
Can cystic fibrosis patients receive lung transplants?
Yes, CF is a common indication for lung transplant. Bilateral transplant is required to remove all infected tissue. Outcomes for CF patients are generally good with appropriate selection.
What is primary graft dysfunction?
PGD is acute lung injury in the first 72 hours after transplant, affecting 10-25% of recipients. It ranges from mild to severe and is managed with supportive care including ECMO if needed.
How is rejection monitored after lung transplant?
Surveillance includes regular bronchoscopies with biopsies (frequently in first year), pulmonary function tests, and chest imaging. Patients also monitor for symptoms like decreased exercise tolerance or new cough.

Important Information

Organ transplantation involves complex medical, ethical, and legal considerations. China operates a voluntary citizen organ donation system based on deceased donation after death, established in 2015. Eligibility for foreign patients depends on multiple factors including medical urgency, donor availability, and current regulations. Please contact us for current eligibility criteria and program availability.

Learn More About Transplant Options

Get information about transplant evaluation, eligibility, and care pathways.

Other Transplant Programs